[Form 4] Jasper Therapeutics, Inc. Insider Trading Activity

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Form 4/A overview: Dave & Buster鈥檚 Entertainment, Inc. (ticker PLAY) filed an amended Form 4 covering Chief Financial Officer Darin Harper鈥檚 equity transactions.

Administrative correction: The filing replaces an earlier Form 4 to fix an incorrect share price in Table I and to add missing data in Table II.
Tax-withholding share deductions (Code F): On 24 Jun 2025 the issuer withheld 1,144 shares (1,010 + 134) at $31.86 each to cover taxes upon vesting of two previously granted RSU tranches (4,147 and 547 RSUs, respectively). No open-market sale occurred.
New equity awards (Code A):

3,014 new RSUs granted on 27 Jun 2025; vest in three equal annual installments beginning 24 Apr 2026.
9,085 stock options (strike $33.02, exp. 20 Dec 2034) became effective 18 Jun 2025 after shareholder approval of the 2025 Omnibus Incentive Plan; options vest in three equal tranches starting 20 Dec 2025.
3,014 stock options (strike $30.45, exp. 27 Jun 2035) granted 27 Jun 2025; vest annually from 24 Apr 2026.

Post-transaction holdings: Harper now directly owns 54,943 common shares and holds derivative rights on 12,099 options.

Investor takeaway: All activity relates to routine executive compensation and tax withholding; there are no open-market purchases or sales. The filing is therefore generally viewed as neutral from a market-impact standpoint.

Form 4/A 臧滌殧: Dave & Buster鈥檚 Entertainment, Inc. (韹办护 PLAY)臧€ 斓滉碃鞛毂呾瀯鞛�(CFO) Darin Harper鞚� 欤检嫕瓯半灅鞐� 甏€頃� 靾橃爼霅� Form 4毳� 鞝滌稖頄堨姷雼堧嫟.

頄夓爼鞝� 靾橃爼: 鞚挫爠 Form 4毳� 雽€觳错晿鞐� 響� I鞚� 鞛橂霅� 欤缄皜毳� 靾橃爼頃橁碃響� II鞚� 雸勲澖霅� 雿办澊韯半ゼ於旉皜頄堨姷雼堧嫟.
靹戈笀鞗愳矞歆曥垬欤检嫕瓿奠牅(旖旊摐 F): 2025雲� 6鞗� 24鞚�, 氚滍枆靷姅鞚挫爠鞐� 攵€鞐悳霊� 臧滌潣 RSU 韸鸽灉旃�(臧侁皝 4,147 氚� 547 RSU)鞚� 甓岆Μ 頇曥爼鞁� 靹戈笀鞚� 於╇嫻頃橁赴鞙勴暣臧侁皝 $31.86鞐� 1,144欤�(1,010 + 134)毳� 鞗愳矞歆曥垬頄堨姷雼堧嫟. 瓿店皽鞁滌灔毵る弰電� 鞐嗢棃鞀惦媹雼�.
鞁犼窚欤检嫕靾橃棳(旖旊摐 A):

2025雲� 6鞗� 27鞚检棎 3,014臧滌潣鞁犼窚 RSU臧€ 攵€鞐悩鞐堨溂氅�, 2026雲� 4鞗� 24鞚茧秬韯� 鞁滌瀾頃橃棳 3雲勱皠鞐半摫攵勴晿鞐� 甓岆Μ臧€ 頇曥爼霅╇媹雼�.
欤检＜鞀轨澑頉� 2025雲� 6鞗� 18鞚检棎氚滍毃霅� 2025雲� 齑濌磩鞚胳劶韹半笇頂岆灉鞐� 霐半澕 9,085臧滌潣欤检嫕鞓奠厴(頄夓偓臧€瓴� $33.02, 毵岆鞚� 2034雲� 12鞗� 20鞚�)鞚� 攵€鞐悩鞐堨溂氅�, 2025雲� 12鞗� 20鞚茧秬韯� 3須岇棎瓯胳硱攴犽摫頃橁矊甓岆Μ臧€ 頇曥爼霅╇媹雼�.
2025雲� 6鞗� 27鞚检棎 3,014臧滌潣欤检嫕鞓奠厴(頄夓偓臧€瓴� $30.45, 毵岆鞚� 2035雲� 6鞗� 27鞚�)鞚� 攵€鞐悩鞐堨溂氅�, 2026雲� 4鞗� 24鞚茧秬韯� 毵る厔甓岆Μ臧€ 頇曥爼霅╇媹雼�.

瓯半灅頉� 氤挫湢順勴櫓: Harper電� 順勳灛歆侅爲 54,943欤� 氤错喌欤�毳� 氤挫湢頃橁碃鞛堨溂氅�, 12,099臧� 鞓奠厴鞐� 雽€頃� 韺岇儩甓岆Μ毳� 氤挫湢頃橁碃鞛堨姷雼堧嫟.

韴瀽鞛� 鞁滌偓鞝�: 氇摖頇滊彊鞚€ 鞚检儊鞝侅澑鞛勳洂氤挫儊氚� 靹戈笀鞗愳矞歆曥垬鞕€ 甏€霠悩鞏� 鞛堨溂氅�, 瓿店皽鞁滌灔鞐愳劀鞚� 毵るГ電� 鞐嗢姷雼堧嫟. 霐半澕靹� 鞚措矆鞝滌稖鞚€ 鞁滌灔鞓來枼旄‰┐鞐愳劀鞚茧皹鞝侅溂搿� 欷戨鞝�鞙茧 臧勳＜霅╇媹雼�.

Insights

TL;DR: Routine equity awards; no buying or selling鈥攎inimal market impact.

The CFO鈥檚 transactions are entirely compensation-related. The 1,144 shares deducted were withheld for taxes, not sold in the market, so there is no bearish signal. New RSUs and 12,099 stock options align the executive鈥檚 incentives with shareholder value over the next 3鈥�10 years but do not immediately alter supply-demand dynamics. Given the absence of open-market activity and the modest scale (total direct holdings 鈮�55k shares, <0.1% of outstanding), I classify the filing as neutral for valuation or sentiment purposes.

頄夓爼鞝� 靾橃爼: 鞚挫爠 Form 4毳� 雽€觳错晿鞐� 響� I鞚� 鞛橂霅� 欤缄皜毳� 靾橃爼頃橁碃響� II鞚� 雸勲澖霅� 雿办澊韯半ゼ於旉皜頄堨姷雼堧嫟.
靹戈笀鞗愳矞歆曥垬欤检嫕瓿奠牅(旖旊摐 F): 2025雲� 6鞗� 24鞚�, 氚滍枆靷姅鞚挫爠鞐� 攵€鞐悳霊� 臧滌潣 RSU 韸鸽灉旃�(臧侁皝 4,147 氚� 547 RSU)鞚� 甓岆Μ 頇曥爼鞁� 靹戈笀鞚� 於╇嫻頃橁赴鞙勴暣臧侁皝 $31.86鞐� 1,144欤�(1,010 + 134)毳� 鞗愳矞歆曥垬頄堨姷雼堧嫟. 瓿店皽鞁滌灔毵る弰電� 鞐嗢棃鞀惦媹雼�.
鞁犼窚欤检嫕靾橃棳(旖旊摐 A):

2025雲� 6鞗� 27鞚检棎 3,014臧滌潣鞁犼窚 RSU臧€ 攵€鞐悩鞐堨溂氅�, 2026雲� 4鞗� 24鞚茧秬韯� 鞁滌瀾頃橃棳 3雲勱皠鞐半摫攵勴晿鞐� 甓岆Μ臧€ 頇曥爼霅╇媹雼�.
欤检＜鞀轨澑頉� 2025雲� 6鞗� 18鞚检棎氚滍毃霅� 2025雲� 齑濌磩鞚胳劶韹半笇頂岆灉鞐� 霐半澕 9,085臧滌潣欤检嫕鞓奠厴(頄夓偓臧€瓴� $33.02, 毵岆鞚� 2034雲� 12鞗� 20鞚�)鞚� 攵€鞐悩鞐堨溂氅�, 2025雲� 12鞗� 20鞚茧秬韯� 3須岇棎瓯胳硱攴犽摫頃橁矊甓岆Μ臧€ 頇曥爼霅╇媹雼�.
2025雲� 6鞗� 27鞚检棎 3,014臧滌潣欤检嫕鞓奠厴(頄夓偓臧€瓴� $30.45, 毵岆鞚� 2035雲� 6鞗� 27鞚�)鞚� 攵€鞐悩鞐堨溂氅�, 2026雲� 4鞗� 24鞚茧秬韯� 毵る厔甓岆Μ臧€ 頇曥爼霅╇媹雼�.

瓯半灅頉� 氤挫湢順勴櫓: Harper電� 順勳灛歆侅爲 54,943欤� 氤错喌欤�毳� 氤挫湢頃橁碃鞛堨溂氅�, 12,099臧� 鞓奠厴鞐� 雽€頃� 韺岇儩甓岆Μ毳� 氤挫湢頃橁碃鞛堨姷雼堧嫟.

07/03/2025 - 04:24 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

EMSTER KURT VON

(Last)

(First)

(Middle)

C/O JASPER THERAPEUTICS, INC.

2200 BRIDGE PKWY, SUITE #102

(Street)

REDWOOD CITY

94065

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Jasper Therapeutics, Inc. [ JSPR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$6.77	07/03/2025		A		7,500⁽¹⁾		07/03/2026	07/03/2035	Voting Common Stock	7,500	$0.00	7,500	D

Explanation of Responses:

1. Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders.

	By: /s/ Herb Cross, as Attorney-in-Fact	07/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

AG真人官方